2014 Volume 29 Issue 3 Pages 239-242
The ubiquitous nature of microbiology is reflected in the diversity of microbiological research and operational efforts at NASA. For example, the impact of microorganisms on other planets and the protection of Earth from the potential of microbial life elsewhere is the responsibility of the Office of Planetary Protection (http://planetaryprotection.nasa.gov/about). While the Office of Planetary Protection does not include forward or back contamination to or from a low Earth orbit, research platforms, such as the ISS, are being used to better understand the survival of microorganisms and corresponding contamination control in the extreme conditions of space (2, 4, 10). Another example is the NASA Center for Astrobiology, which focuses on the origin, evolution, distribution, and future of life in the universe (https://astrobiology.nasa.gov/). The large focus on microbiology is within its human exploration operations. NASA has historically set microbiological requirements, including stringent monitoring regimes, to mitigate risks to the health and performance of astronauts. Microorganisms can have both positive and negative impacts on many aspects of human spaceflight, including the risk and prevention of infectious diseases, performance of Environmental Control and Life Support Systems (ECLSS), spaceflight foods, and vehicle design and integrity. Even though a great amount of information has been obtained (1, 5, 7, 8), several key questions regarding the impact of microorganisms on human spaceflight still remain. Research into the uncertainties of risks that may affect crew health are the responsibility of the NASA Human Research Program (http://www.nasa.gov/exploration/humanresearch/). The research that addresses our fundamental understanding of space life science and its translation for benefits to the general public on Earth is the responsibility of NASA Space Biology.
Microbial research by the NASA Human Research Program has investigated changes in microbial hazards, infectious disease: dose-responses, and crew exposure that could impact the health and performance of the crew during a spaceflight mission. In order to achieve its goals, the NASA Human Research Program performs ground-based and spaceflight studies designed to decrease uncertainties in our knowledge of current risks entitled “Risk of Adverse Health Effects Due to Alterations in Host-Microorganism Interactions”. Details on the content of this research can be found at http://humanresearchroadmap.nasa.gov/Risks/?i=80. An example of studies being performed in this program is the spaceflight experiment, a study on the impact of long-term space travel on the astronaut’s microbiome, led by Principal Investigator Dr. Hernan Lorenzi of the J Craig Venter Institute. This study has been designed to evaluate changes in the astronaut microbiome that may be occurring during spaceflight missions, which could impact their health and performance. This experiment will use state-of-the-art techniques to determine fluctuations in the bacterial and viral microbiome of astronauts from key body sites before, during, and after a space mission. In addition, key immunological and environmental parameters will be monitored.
The NASA Space Biology Program performs basic microbiological research, including both ground-based and spaceflight studies, which enhances our understanding of microorganisms and their unique responses to spaceflight culture. The broad scope of microbiology research by the NASA Space Biology Program can be found in the Fundamental Space Biology Science Plan at http://www.nasa.gov/exploration/library/esmd_documents.html. An example of this research is the spaceflight experiment, an investigation of host-pathogen interactions, conserved cellular responses, and countermeasure efficacies during spaceflight using the human surrogate model Caenorhabditis elegans, led by Principal Investigator Dr. Cheryl Nickerson of the Biodesign Institute at Arizona State University. This study builds upon Dr. Nickerson’s previous findings that Salmonella enterica serovar Typhimurium displayed increases in virulence when cultured during spaceflight. In this latest experiment, changes in virulence and genetic regulation are being evaluated when both the host and pathogen are simultaneously exposed to the spaceflight environment. In addition to inflight monitoring of the infection process, this study will also evaluate the impact of altering media components to better define the mechanisms underlying this spaceflight effect.
The need for microbiology in NASA’s research goals was reinforced by the National Academy of Sciences in their 2011 report, “Recapturing a Future for Space Exploration: Life and Physical Sciences Research for a New Era” (6), commonly referred to as the Decadal Survey. Included in their recommendations was the need to:
These recommendations have established the groundwork for future microbiological research, which intersects with multiple NASA programs. NASA research will continue to provide exciting new findings and create opportunities for greater collaborations and utilization of the International Space Station (ISS) platform. Most importantly, the knowledge gained from studies, such as the “Microbial Observatory” initiative, hold the potential to improve the health and performance of spaceflight crews and translate into important findings for scientists on Earth.
The JAXA has solicited research opportunities onboard Kibo, and research related to microbial monitoring, as shown in Table 1, have been selected.
| Experiment Name | Experiment Title | Principle Investigator | Status | References |
|---|---|---|---|---|
| Microbe-1 | Studies on microbiota on board International Space Station and their relationship to health problems (combined with “Microbial monitoring on the ISS”) (selected in 2007) |
Makimura, K. (Teikyo Univ.) Nasu, M. (Osaka Univ.) |
Microbe-1: Conducted in 2009 | (3, 9, 11) |
| Microbe-2 | Microbe-2: Conducted in 2011 | |||
| Microbe-3 | Microbe-3: Conducted in 2012 | |||
|
| ||||
| Microbe-A | On-board microorganism monitoring in spacecrafts (selected in 2010) | Yamazaki, T. (Teikyo Univ./JAXA) | Experiment definition ongoing | http://iss.jaxa.jp/en/kiboexp/theme/second/pmlatter/yamazaki_e.pdf |
|
| ||||
| Microbe-4 | “Microbe”: Microbial monitoring in the International Space Station—KIBO (selected in 2012) | Nasu, M. (Osaka Univ.) | Experiment definition ongoing | http://iss.jaxa.jp/en/kiboexp/scenario/selection/fy2014_general/ |
“Microbe-1” to “Microbe-3” are a series of experiments that monitor microbial dynamics in the Kibo module and were initiated just before Kibo was launched. The objective of “Microbe” is to constantly monitor the microbes in Kibo that may affect crew members’ health and the ISS systems and facilities. Experiment data will be used to evaluate the stress caused by microbes on crew members as the medical impact of living on a space station. Fig. 1A shows a typical sampling location inside the Kibo module. The features of “Microbe” are as follows:
(A) Typical sampling location inside the Kibo module for “Microbe-1, 2, 3” experiments. (B) Air sampling with the NASA Air Sampler Device (left) and JAXA Particle Counter (right) in the Microbe-3 experiment.
New hardware, a commercial handheld Particle Counter (KR-12A, Rion) that was customized for flight, was introduced in the “Microbe-3” experiment, (Fig. 1B [right]). This particle counter has the following functions: 1) Detect particles floating in the air; 2) Display a particle count for six ranges in size of ≥0.5 μm, ≥1.0 μm, ≥2.0 μm, ≥3.0 μm, ≥5.0 μm, and ≥10.0 μm; 3) Store up to 500 measurements; 4) Downlink the data through a laptop terminal in Kibo; 5) Operate for approximately 30 h with four D-cell alkaline batteries. The particle counter was launched by HTV-3 in July, 2012. During the “Microbe-3” experiment and used to count particles in the Kibo module in September-October timeframe, 2012.
Air samples were also collected at the same time using the NASA Air Sampling Device (ASD) for the SWAB project, which was borrowed from NASA (Fig. 1B [left]). JAXA fabricated a newly designed battery holder for the SWAB ASD.
On-going microbial monitoring in KIBO will be continued and expanded in the “Microbe-4” experiment. The objective of “Microbe-4” is to accumulate fundamental data on microbial dynamics in space habitation environments in order to define correct upper and lower thresholds for the indoor environmental quality control of air, water, and surfaces in this unique habitat.
Onboard microbial monitoring systems are planned for use in the “Microbe-A” experiment. These devices will not require sample recovery to the ground and will allow crew members to evaluate risks and impact promptly onboard Kibo. The purpose of “Microbe-A” is to develop and demonstrate a rapid and effective onboard monitoring system for crew members to monitor microorganisms in the ISS cabin environment. On-site and real-time microbial monitoring systems will be developed to protect crew members from harmful microorganisms. Crew members will be able to monitor microflora in their living environment on-orbit and immediately take countermeasures against microbial contamination. The development of onboard monitoring facilities based on ground-based microbial monitoring technologies has been studied. Candidates are Loop-Mediated Isothermal Amplification (called “LAMP”; http://loopamp.eiken.co.jp/e/tech/index.html) and a fluorescent microscope-based system for enumeration with a newly designed microfluidic device for cell counting (12).
The JAXA president’s advisory committee to promote the utilization of ISS/Kibo developed “Kibo utilization scenarios (strategic plans) toward 2020” in March 2012. These scenarios were developed in the disciplines of life sciences, space medicine, and physical sciences (http://iss.jaxa.jp/en/kiboexp/scenario/). Future microbial research in the scenario for life sciences has been described as follows: “A priority item is ‘Research on the relationship between microbes and humans in space’. The ISS is a completely closed environment that offers a long-term microgravity environment. Therefore, it is a unique environment in which microbes can move and attach themselves to devices or humans (especially the exposed part of the body and head). Monitoring microbes inside Kibo and analyzing their movement must be continued to study their influence on humans and to prevent health hazards caused by these microbes during a long-term space mission. In addition, an integrated monitoring and analysis system needs to be established in cooperation with NASA (USA), ESA (EU), and ROSCOSMOS (Russia), not only for inside Kibo, but also the entire ISS.”
The scenario also states that the following area should be promoted:
The International Space Station program is one of the biggest international cooperative projects in the world. Onboard research should also be promoted by international collaborations. This collaboration will be necessary, especially for microbial research, because the cabin or internal environment inside the ISS is common and the environment will mutually affect each agency’s module, facilities, and onboard crew members. However, although microbial environment conditions are commonly assessed in terms of medical operations (i.e. a minimum screening level), microbial research to support or advance these activities (e.g. validation of the current threshold) have so far been conducted individually by each space agency. Therefore, JAXA has proposed the following possible international collaborations or activities to the other international partners.
JAXA expects that microbial research on the ISS/Kibo is also beneficial on the ground such as the establishment of a process to monitor an environment that requires specific quality control, the spin-off of handy, reliable devices developed for space experiments, and applications to health and environmental control.
